Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Coroflex® ISAR NEO PMCF Study

NCT: NCT05698732 · RECRUITING

NCT IDNCT05698732
StatusRECRUITING
Start Date2023-08-04
Completion2027-02-01

Brief Summary

International, Multicenter, prospective, non-randomized, post-market clinical follow-up (PMCF) study to confirm and support the clinical safety and performance of Coroflex® ISAR NEO coronary stent system to meet EU Medical Device regulation (MDR) requirements in all the CONSECUTIVE patients treated with Coroflex® ISAR NEO coronary stent system sirolimus eluting stent.

Frequently Asked Questions

What is Coroflex® ISAR NEO PMCF Study?

Coroflex® ISAR NEO PMCF Study is a clinical trial registered under NCT05698732. Current status: RECRUITING.

What is the status of NCT05698732?

The current status of NCT05698732 (Coroflex® ISAR NEO PMCF Study) is: RECRUITING.

When did Coroflex® ISAR NEO PMCF Study start?

Coroflex® ISAR NEO PMCF Study started on 2023-08-04.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑